Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (230) 230
Publication (55) 55
Conference Proceeding (6) 6
Book / eBook (3) 3
Book Chapter (2) 2
Newspaper Article (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (147) 147
index medicus (111) 111
hematology (99) 99
male (96) 96
female (93) 93
oncology (89) 89
middle aged (85) 85
aged (78) 78
antineoplastic combined chemotherapy protocols - therapeutic use (76) 76
adult (72) 72
chemotherapy (54) 54
rituximab (53) 53
prognosis (46) 46
non-hodgkins-lymphoma (45) 45
treatment outcome (44) 44
disease-free survival (36) 36
lymphomas (33) 33
adolescent (31) 31
neoplasm staging (30) 30
retrospective studies (30) 30
antineoplastic combined chemotherapy protocols - adverse effects (29) 29
aged, 80 and over (27) 27
cyclophosphamide - administration & dosage (24) 24
cancer (23) 23
survival analysis (23) 23
young adult (23) 23
antineoplastic combined chemotherapy protocols - administration & dosage (21) 21
prednisone - administration & dosage (21) 21
therapy (21) 21
vincristine - administration & dosage (21) 21
disease (20) 20
doxorubicin - administration & dosage (20) 20
elderly-patients (20) 20
hematology, oncology and palliative medicine (20) 20
lymphoma (20) 20
risk factors (20) 20
b-cell lymphoma (19) 19
hemic and lymphatic diseases (19) 19
recurrence (19) 19
survival (19) 19
combined modality therapy (18) 18
cyclophosphamide (18) 18
italy (18) 18
phase-ii (18) 18
antineoplastic agents - therapeutic use (17) 17
lymphoma, large b-cell, diffuse - drug therapy (17) 17
antibodies, monoclonal, murine-derived - administration & dosage (16) 16
hodgkin disease - drug therapy (16) 16
lymphoma, non-hodgkin - drug therapy (16) 16
transplantation (16) 16
lymphoma, follicular - pathology (15) 15
stem-cell transplantation (15) 15
trial (15) 15
abridged index medicus (14) 14
follow-up studies (14) 14
high-dose chemotherapy (14) 14
bone-marrow-transplantation (13) 13
follicular lymphoma (13) 13
lymphoma, follicular - drug therapy (13) 13
patients (13) 13
transplantation, autologous (13) 13
care and treatment (12) 12
remission induction (12) 12
salvage therapy (12) 12
stem cells (12) 12
cyclophosphamide - therapeutic use (11) 11
fdg-pet (11) 11
follow-up (11) 11
hematopoietic stem cell transplantation (11) 11
positron-emission-tomography (11) 11
prospective studies (11) 11
randomized controlled-trial (11) 11
research (11) 11
stem cell transplantation (11) 11
survival rate (11) 11
1st-line treatment (10) 10
aggressive lymphoma (10) 10
bleomycin - administration & dosage (10) 10
clinical trials (10) 10
doxorubicin (10) 10
doxorubicin - therapeutic use (10) 10
fludarabine (10) 10
hodgkin's disease (10) 10
kaplan-meier estimate (10) 10
patient outcomes (10) 10
prednisone - therapeutic use (10) 10
rituximab - administration & dosage (10) 10
vincristine - therapeutic use (10) 10
analysis (9) 9
chronic lymphocytic-leukemia (9) 9
cyclophosphamide - adverse effects (9) 9
diffuse large b-cell lymphoma (9) 9
doxorubicin - adverse effects (9) 9
drug therapy (9) 9
gene-expression (9) 9
hodgkin disease - mortality (9) 9
lymphoma, large b-cell, diffuse - mortality (9) 9
lymphoma, large b-cell, diffuse - pathology (9) 9
lymphoma, non-hodgkin - pathology (9) 9
lymphoma, non-hodgkin - therapy (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
by Umberto Vitolo and Annalisa Chiappella and Andrés J.M. Ferreri and Maurizio Martelli and Ileana Baldi and Monica Balzarotti and Chiara Bottelli and Annarita Conconi and Henry Gomez and Armando Lopez-Guillermo and Giovanni Martinelli and Francesco Merli and Domenico Novero and Lorella Orsucci and Vincenzo Pavone and Umberto Ricardi and Sergio Storti and Mary K. Gospodarowicz and Franco Cavalli and Andreas H. Sarris and Emanuele Zucca
Journal of Clinical Oncology, ISSN 0732-183X, 07/2011, Volume 29, Issue 20, pp. 2766 - 2772
Purpose Primary testicular lymphoma (PTL) has poor prognosis with failures in contralateral testis, CNS, and extranodal sites. To prevent these events, we... 
RICOVER-60 | PROGNOSTIC-FACTORS | RESPONSE CRITERIA | ONCOLOGY | MALIGNANT-LYMPHOMA | NON-HODGKINS-LYMPHOMA | CENTRAL-NERVOUS-SYSTEM | RECURRENCE | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Doxorubicin - therapeutic use | Recurrence | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Testicular Neoplasms - pathology | Central Nervous System Neoplasms - secondary | Testicular Neoplasms - radiotherapy | Central Nervous System Neoplasms - prevention & control | Drug-Related Side Effects and Adverse Reactions | Adult | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Lymphoma, Large B-Cell, Diffuse - pathology | Rituximab | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Methotrexate - adverse effects | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Methotrexate - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Brentuximab vedotin-based salvage treatment in Hodgkin's lymphoma
by Vitolo, Umberto and Chiappella, Annalisa
The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1144 - 1146
BENDAMUSTINE | TRIAL | DOSE-ESCALATION | VINORELBINE | ONCOLOGY | MULTICENTER PHASE-II | COMBINATION | GEMCITABINE | TRANSPLANTATION | Young Adult | Immunoconjugates | Hodgkin Disease | Humans | Salvage Therapy | Child | Deoxycytidine - analogs & derivatives
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma
by Filippi, Andrea Riccardo, MD and Ciammella, Patrizia, MD and Piva, Cristina, MD and Ragona, Riccardo, MSc and Botto, Barbara, MD and Gavarotti, Paolo, MD and Merli, Francesco, MD and Vitolo, Umberto, MD and Iotti, Cinzia, MD and Ricardi, Umberto, MD
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 2, pp. 370 - 375
Purpose Image-guided intensity modulated radiation therapy (IG-IMRT) allows for margin reduction and highly conformal dose distribution, with consistent... 
Radiology | Hematology, Oncology and Palliative Medicine | ABVD | ONCOLOGY | BREAST-CANCER RISK | NODE RADIOTHERAPY | DISEASE | FIELD RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - pathology | Humans | Middle Aged | Male | Vinblastine - administration & dosage | Radiotherapy, Intensity-Modulated - adverse effects | Young Adult | Hodgkin Disease - radiotherapy | Mediastinal Neoplasms - drug therapy | Aged, 80 and over | Hodgkin Disease - drug therapy | Adult | Female | Retrospective Studies | Radiotherapy, Image-Guided - adverse effects | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Radiotherapy, Intensity-Modulated - methods | Bleomycin - administration & dosage | Tumor Burden | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Radiotherapy, Image-Guided - methods | Mediastinal Neoplasms - radiotherapy | Adolescent | Radiotherapy, Conformal - adverse effects | Aged | Combined Modality Therapy - methods | Radiotherapy, Conformal - methods | Sects | Lymphomas | Radiotherapy | Nuclear radiation | Index Medicus | PATIENTS | DOXORUBICIN | BLEOMYCIN | VINBLASTINE | RADIATION DOSES | TOXICITY | PLANNING | LYMPHOMAS | RADIATION DOSE DISTRIBUTIONS | MEDIASTINUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Salvage regimens for Hodgkin's lymphoma in the brentuximab vedotin era
by Vitolo, Umberto and Chiappella, Annalisa
The Lancet Oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 162 - 163
ONCOLOGY | MULTICENTER PHASE-II | TRANSPLANTATION | Bendamustine Hydrochloride | Immunoconjugates | Child | Hodgkin Disease | Humans | Salvage Therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
by Vitolo, Umberto, Dr and Chiappella, Annalisa, MD and Franceschetti, Silvia, MD and Carella, Angelo Michele, MD and Baldi, Ileana, PhD and Inghirami, Giorgio, Prof and Spina, Michele, MD and Pavone, Vincenzo, MD and Ladetto, Marco, MD and Liberati, Anna Marina, Prof and Molinari, Anna Lia, MD and Zinzani, Pierluigi, Prof and Salvi, Flavia, MD and Fattori, Pier Paolo, MD and Zaccaria, Alfonso, MD and Dreyling, Martin, Prof and Botto, Barbara, MD and Castellino, Alessia, MD and Congiu, Angela, MD and Gaudiano, Marcello, PhD and Zanni, Manuela, MD and Ciccone, Giovannino, MD and Gaidano, Gianluca, Prof and Rossi, Giuseppe, MD and Fdn Italiana Linfomi and Fondazione Italiana Linfomi
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 730 - 737
Summary Background Up to 40% of elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) given a regimen of rituximab, cyclophosphamide,... 
Hematology, Oncology and Palliative Medicine | RITUXIMAB-CHOP | CLINICAL-TRIAL | ONCOLOGY | R-CHOP | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Thalidomide - adverse effects | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thalidomide - administration & dosage | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - mortality | Thalidomide - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Vincristine - administration & dosage | Vincristine - adverse effects | Female | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Doxorubicin - administration & dosage | Aged patients | Anthracyclines | Product development | Corticosteroids | Angiogenesis inhibitors | Public health | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy
by Filippi, Andrea Riccardo, MD and Piva, Cristina, MD and Giunta, Francesca, MD and Bellò, Marilena, MD and Chiappella, Annalisa, MD and Caracciolo, Daniele, MD and Zotta, Michela, MD and Douroukas, Anastasios, MD and Ragona, Riccardo, PhD and Vitolo, Umberto, MD and Bisi, Gianni, MD and Ricardi, Umberto, MD
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 2, pp. 311 - 316
Purpose To investigate the role of radiation therapy (RT) in patients affected with primary mediastinal B-cell lymphoma (PMBCL) with residual18... 
Radiology | Hematology, Oncology and Palliative Medicine | CONSENSUS | INVOLVED-FIELD RADIOTHERAPY | CHOP | ONCOLOGY | MACOP-B | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Lymphoma, B-Cell - radiotherapy | Male | Mediastinal Neoplasms - mortality | Antineoplastic Agents - therapeutic use | Neoplasm, Residual | Young Adult | Mediastinal Neoplasms - drug therapy | Adult | Female | Lymphoma, B-Cell - diagnostic imaging | Retrospective Studies | Radiopharmaceuticals | Lymphoma, B-Cell - drug therapy | Lymphoma, B-Cell - mortality | Rituximab | Mediastinal Neoplasms - diagnostic imaging | Positron-Emission Tomography - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - radiotherapy | Adolescent | Fluorodeoxyglucose F18 | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Sects | Chemotherapy | PET imaging | Nuclear radiation | Lymphomas | Radiotherapy | Cancer | LYMPHOMAS | DIAGNOSIS | PATIENTS | POSITRON COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | CHEMOTHERAPY | FLUORINE 18
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma – Authors' reply
by Chiappella, Annalisa and Martelli, Maurizio and Evangelista, Andrea and Vitolo, Umberto
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. e558 - e558
Lymphoma, Large B-Cell, Diffuse | Humans | Neoplasm Recurrence, Local | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Rituximab | Transplantation, Autologous | Treatment Outcome | Antibodies, Monoclonal | Lymphoma, B-Cell | Transplantation | Lymphomas | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma
by Nowakowski, Grzegorz S and Vitolo, Umberto
Future Oncology, ISSN 1479-6694, 04/2017, Volume 13, Issue 10, pp. 859 - 862
hematologic/lymphoma | molecular oncology | chemotherapy
Journal Article
Details down arrow
9. Full Text ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
by Viviani, Simonetta and Zinzani, Pier Luigi and Rambaldi, Alessandro and Brusamolino, Ercole and Levis, Alessandro and Bonfante, Valeria and Vitolo, Umberto and Pulsoni, Alessandro and Liberati, Anna Marina and Specchia, Giorgina and Valagussa, Pinuccia and Rossi, Andrea and Zaja, Francesco and Pogliani, Enrico M and Pregno, Patrizia and Gotti, Manuel and Gallamini, Andrea and Scalabrini, Delia Rota and Bonadonna, Gianni and Gianni, Alessandro M and Intergrp Italiano Linfomi and Grp Italiano Terapie Innovative Ne and Michelangelo Fdn and Michelangelo Foundation and Intergruppo Italiano Linfomi and Gruppo Italiano di Terapie Innovative nei Linfomi
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
by Massimo Federico and Monica Bellei and Luigi Marcheselli and Stefano Luminari and Armando Lopez-Guillermo and Umberto Vitolo and Barbara Pro and Stefano Pileri and Alessandro Pulsoni and Pierre Soubeyran and Sergio Cortelazzo and Giovanni Martinelli and Maurizio Martelli and Luigi Rigacci and Luca Arcaini and Francesco Di Raimondo and Francesco Merli and Elena Sabattini and Peter McLaughlin and Philippe Solal-Céligny
Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4555 - 4562
Purpose The aim of the F2 study was to verify whether a prospective collection of data would enable the development of a more accurate prognostic index for... 
SURVIVAL | TRIAL | LOW-GRADE LYMPHOMA | RESPONSE CRITERIA | ONCOLOGY | RITUXIMAB | SERUM BETA-2-MICROGLOBULIN | NON-HODGKINS-LYMPHOMA | MODEL | MULTIVARIATE-ANALYSIS | PREDICTION | Predictive Value of Tests | Lymphoma, Follicular - therapy | Prognosis | Risk Assessment | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Disease Progression | Young Adult | Disease-Free Survival | Aged, 80 and over | Adult | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Prognostic Role of Pre–Radiation Therapy 18F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation
by Filippi, Andrea Riccardo and Piva, Cristina and Levis, Mario and Chiappella, Annalisa and Caracciolo, Daniele and Bellò, Marilena and Bisi, Gianni and Vitolo, Umberto and Ricardi, Umberto
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 07/2016, Volume 95, Issue 4, pp. 1239 - 1243
To validate, in a monoinstitutional cohort with extended follow-up, that post–rituximab chemotherapy (R-CT) F-fluorodeoxyglucose positron emission tomography (... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
by Andrea Gallamini and Martin Hutchings and Luigi Rigacci and Lena Specht and Francesco Merli and Mads Hansen and Caterina Patti and Annika Loft and Francesco Di Raimondo and Francesco D'Amore and Alberto Biggi and Umberto Vitolo and Caterina Stelitano and Rosario Sancetta and Livio Trentin and Stefano Luminari and Emilio Iannitto and Simonetta Viviani and Ivana Pierri and Alessandro Levis
Journal of Clinical Oncology, ISSN 0732-183X, 08/2007, Volume 25, Issue 24, pp. 3746 - 3752
Purpose Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma ( HL) were consecutively enrolled in parallel Italian and Danish... 
FDG-PET | TRIAL | THERAPY | MODELS | ONCOLOGY | DISEASE | BEACOPP | CYCLES | REGIMEN | CHEMOTHERAPY | STANDARD | Hodgkin Disease - diagnostic imaging | Prognosis | Humans | Middle Aged | Male | Survival Rate | Disease-Free Survival | Adolescent | Radionuclide Imaging | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Fluorodeoxyglucose F18 | Aged | Radiopharmaceuticals
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study
by Emanuele Zucca and Annarita Conconi and Daniele Laszlo and Armando López-Guillermo and Reda Bouabdallah and Bertrand Coiffier and Catherine Sebban and Fabrice Jardin and Umberto Vitolo and Franck Morschhauser and Stefano A. Pileri and Christiane Copie-Bergman and Elias Campo and Andrew Jack and Irene Floriani and Peter Johnson and Maurizio Martelli and Franco Cavalli and Giovanni Martinelli and Catherine Thieblemont
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 565 - 572
Purpose Apart from localized gastric disease, there is no consensus on standard initial treatment of mucosa-associated lymphoid tissue lymphoma. The IELSG-19... 
THERAPY | RESPONSE CRITERIA | ONCOLOGY | DISSEMINATION | DISEASE | GASTRIC MALT LYMPHOMA | FOLLOW-UP | PHASE-II | TISSUE LYMPHOMA | CLINICAL ACTIVITY | Chlorambucil - administration & dosage | Drug Administration Schedule | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Rituximab | Male | Treatment Outcome | Remission Induction | Lymphoma, B-Cell, Marginal Zone - mortality | Disease-Free Survival | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Adult | Female | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Prognostic Role of Pre-Radiation Therapy super(18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation
by Filippi, Andrea Riccardo and Piva, Cristina and Levis, Mario and Chiappella, Annalisa and Caracciolo, Daniele and Bello, Marilena and Bisi, Gianni and Vitolo, Umberto and Ricardi, Umberto
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 07/2016, Volume 95, Issue 4, pp. 1239 - 1243
Purpose: To validate, in a monoinstitutional cohort with extended follow-up, that post-rituximab chemotherapy (R-CT) super(18)F-fluorodeoxyglucose positron... 
Journal Article
Details down arrow
15. Full Text Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma
by Franck Morschhauser and John Radford and Achiel Van Hoof and Umberto Vitolo and Pierre Soubeyran and Herve Tilly and Peter C. Huijgens and Arne Kolstad and Francesco d’Amore and Marcos Gonzalez Diaz and Mario Petrini and Catherine Sebban and Pier Luigi Zinzani and Marinus H.J. van Oers and Wim van Putten and Angelika Bischof-Delaloye and Ama Rohatiner and Gilles Salles and Jens Kuhlmann and Anton Hagenbeek
Journal of Clinical Oncology, ISSN 0732-183X, 11/2008, Volume 26, Issue 32, pp. 5156 - 5164
Purpose We conducted an international, randomized, phase III trial to evaluate the efficacy and safety of consolidation with yttrium-90 (Y-90)-ibritumomab... 
1ST-LINE TREATMENT | OLDER PATIENTS | ONCOLOGY | 5-YEAR FOLLOW-UP | HIGH-DOSE THERAPY | NON-HODGKINS-LYMPHOMA | LOW-GRADE | I-131 TOSITUMOMAB | CHOP CHEMOTHERAPY | Y-90 IBRITUMOMAB TIUXETAN | STEM-CELL TRANSPLANTATION | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Lymphoma, Follicular - radiotherapy | Male | Time Factors | Adult | Female | Antigens, CD20 - analysis | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Antibodies, Monoclonal, Murine-Derived | Lymphoma, Follicular - pathology | Europe | Radioimmunotherapy | Rituximab | Treatment Outcome | Canada | Disease-Free Survival | Lymphoma, Follicular - immunology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study
by Zinzani, Pier Luigi and Broccoli, Alessandro and Gioia, Daniela Maria and Castagnoli, Antonio and Ciccone, Giovannino and Evangelista, Andrea and Santoro, Armando and Ricardi, Umberto and Bonfichi, Maurizio and Brusamolino, Ercole and Rossi, Giuseppe and Anastasia, Antonella and Zaja, Francesco and Vitolo, Umberto and Pavone, Vincenzo and Pulsoni, Alessandro and Rigacci, Luigi and Gaidano, Gianluca and Stelitano, Caterina and Salvi, Flavia and Rusconi, Chiara and Tani, Monica and Freilone, Roberto and Pregno, Patrizia and Borsatti, Eugenio and Sacchetti, Gian Mauro and Argnani, Lisa and Levis, Alessandro
Journal of Clinical Oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 12, pp. 1376 - 1385
Purpose The clinical impact of positron emission tomography (PET) evaluation performed early during first-line therapy in patients with advanced-stage Hodgkin... 
SURVIVAL | ABVD | ONCOLOGY | 2 CYCLES | BEACOPP | DISEASE | PROGNOSTIC SCORE | REGIMEN | PET | CHEMOTHERAPY | STANDARD | Hodgkin Disease - diagnostic imaging | Predictive Value of Tests | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Patient Selection | Young Adult | Time Factors | Hodgkin Disease - mortality | Adult | Female | Stem Cell Transplantation - mortality | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Italy | Aged | Drug Substitution | Neoplasm Staging | Stem Cell Transplantation - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
by Castellino, Alessia and Vitolo, Umberto
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 12/2016, Volume 9, Issue 1, p. e2017009
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy
by Squadrone, Vincenzo and Massaia, Massimo and Bruno, Benedetto and Marmont, Filippo and Falda, Michele and Bagna, Carlotta and Bertone, Stefania and Filippini, Claudia and Slutsky, Arthur S and Vitolo, Umberto and Boccadoro, Mario and Ranieri, V Marco
Intensive Care Medicine, ISSN 0342-4642, 10/2010, Volume 36, Issue 10, pp. 1666 - 1674
Although chemotherapy and transplantation improve outcome of patients with hematological malignancy, complications of these therapies are responsible for a... 
Pediatrics | Pain Medicine | Pneumology/Respiratory System | Emergency Medicine | CPAP | Medicine & Public Health | Intensive / Critical Care Medicine | Acute respiratory failure | Anesthesiology | Hematological cancer | Mechanical ventilation | MARROW TRANSPLANT RECIPIENTS | PROGNOSTIC-FACTORS | CARDIOGENIC PULMONARY-EDEMA | RANDOMIZED CONTROLLED-TRIAL | INTENSIVE-CARE-UNIT | ACUTE RESPIRATORY-FAILURE | POSITIVE AIRWAY PRESSURE | STEM-CELL TRANSPLANTATION | NONINVASIVE VENTILATION | CRITICAL CARE MEDICINE | Continuous Positive Airway Pressure | Intensive Care Units | Acute Lung Injury - prevention & control | Humans | Survival Analysis | Pneumonia - complications | Sepsis - complications | Hematologic Neoplasms - complications | Hematologic Neoplasms - physiopathology | Acute respiratory distress syndrome | Complications and side effects | Care and treatment | Continuous positive airway pressure | Patient outcomes | Leukemia | Research | Health aspects | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights